ABBOTT LABORATORIES (ABL.DE) Stock Income Statement
Europe - FRA:ABL - US0028241000 - Common Stock
110.48 EUR
-0.2 (-0.18%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 43.84B | 41.95B | 40.11B | 43.65B | 43.08B | |||
| Cost Of Goods | 19.21B | 18.64B | 17.92B | 19.08B | 18.49B | |||
| Gross Profit | 24.63B | 23.31B | 22.19B | 24.57B | 24.59B | |||
| Operating Expenses | 16.61B | 16.31B | 15.47B | 15.86B | 16.00B | |||
| Research and Development | 2.87B | 2.78B | 2.62B | 2.74B | 2.73B | |||
| Selling, General, and Administrative Expenses | 12.02B | 11.65B | 10.88B | 11.11B | 11.22B | |||
| Operating Income | 8.02B | 6.99B | 6.72B | 8.71B | 8.59B | |||
| Interest Income/Expense | -143.00M | -188.00M | -293.00M | -377.00M | -491.00M | |||
| Other Income/Expense | 602.00M | 558.00M | 518.00M | 366.00M | 277.00M | |||
| Non Recurring Items | -342.00M | -350.00M | -283.00M | -390.00M | -163.00M | |||
| Income Before Taxes | 8.14B | 7.01B | 6.66B | 8.31B | 8.21B | |||
| Income Tax | -5.84B | -6.39B | 941.00M | 1.37B | 1.14B | |||
| Net Income | 13.98B | 13.40B | 5.72B | 6.93B | 7.07B | |||
| EBITDA | N/A | 10.21B | 9.96B | 11.97B | 12.13B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 8.01 | 7.67 | 3.27 | 3.93 | 3.95 | |||
| Non GAAP EPS | 4.99 | 4.67 | 4.44 | 5.34 | 5.21 | |||
| Statistics | ||||||||
| Gross Profit Margin | 56.19% | 55.56% | 55.32% | 56.28% | 57.07% | |||
| Profit Margin | 31.88% | 31.95% | 14.27% | 15.88% | 16.42% | |||
| Operating Profit Margin | 18.29% | 16.67% | 16.76% | 19.95% | 19.94% | |||
All data in USD